Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04167514
PHASE3

Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone

Sponsor: CSL Behring

View on ClinicalTrials.gov

Summary

Study CSL964\_5001 will investigate the efficacy of AAT with corticosteroids compared with corticosteroids alone as first line therapy for patients with high-risk acute GVHD

Official title: A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase III Trial of Alpha 1 - Antitrypsin (AAT) Combined With Corticosteroids vs Corticosteroids Alone for the Treatment of High Risk Acute Graft-versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplant

Key Details

Gender

All

Age Range

12 Years - Any

Study Type

INTERVENTIONAL

Enrollment

136

Start Date

2020-01-09

Completion Date

2024-06-26

Last Updated

2026-07-28

Healthy Volunteers

No

Interventions

BIOLOGICAL

Alpha-1 antitrypsin (AAT)

AAT is a lyophilized product for intravenous administration

DRUG

Placebo

Albumin solution administered intravenously

Locations (25)

Stanford University

Stanford, California, United States

University of Florida

Gainesville, Florida, United States

Moffitt Cancer Center

Tampa, Florida, United States

Emory University

Atlanta, Georgia, United States

Northside Hospital

Atlanta, Georgia, United States

IU Hospital

Indianapolis, Indiana, United States

Univ. of Kansas Cancer Center

Westwood, Kansas, United States

Johns Hopkins Hospital

Baltimore, Maryland, United States

Dana Farber Cancer Institute

Boston, Massachusetts, United States

U-M Medical Center

Ann Arbor, Michigan, United States

Karmanos Cancer Center

Detroit, Michigan, United States

University of Minnesota

Minneapolis, Minnesota, United States

Washington University

St Louis, Missouri, United States

MSKCC

New York, New York, United States

Levine Cancer Center

Charlotte, North Carolina, United States

Duke

Durham, North Carolina, United States

Cleveland Clinic

Cleveland, Ohio, United States

Ohio State Univ.Medical Center

Columbus, Ohio, United States

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, United States

Center for Gene Therapy

Houston, Texas, United States

MD Anderson Cancer Center

Houston, Texas, United States

Virginia Commonwealth Univ.

Richmond, Virginia, United States

Fred Hutchinson Clinic

Seattle, Washington, United States

University of Wisconsin

Madison, Wisconsin, United States

Medical College of Wisconsin

Milwaukee, Wisconsin, United States